# Fish OIL Optimal dosE Determination Study

> **NCT01146821** · PHASE2 · TERMINATED · sponsor: **University Hospital Carl Gustav Carus** · enrollment: 7 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DIETARY_SUPPLEMENT:** 0.20 gm/kg fish oil
- **DIETARY_SUPPLEMENT:** 0.50 gm/kg fish oil

## Key facts

- **NCT ID:** NCT01146821
- **Lead sponsor:** University Hospital Carl Gustav Carus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Low enrollment/ expiration of the grant
- **Last updated:** 2017-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01146821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01146821, "Fish OIL Optimal dosE Determination Study". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT01146821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
